These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 9597251

  • 21. Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia.
    Jones RN, Jacobs MR, Sader HS.
    Int J Antimicrob Agents; 2010 Sep; 36(3):197-204. PubMed ID: 20558045
    [Abstract] [Full Text] [Related]

  • 22. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae.
    Appelbaum PC.
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S29-34. PubMed ID: 10984325
    [Abstract] [Full Text] [Related]

  • 23. Risk Factors for Community-Onset Pneumonia Caused by Levofloxacin-Nonsusceptible Streptococcus pneumoniae.
    Seok H, Kang CI, Huh K, Cho SY, Ha YE, Chung DR, Peck KR.
    Microb Drug Resist; 2018 Nov; 24(9):1412-1416. PubMed ID: 29565225
    [Abstract] [Full Text] [Related]

  • 24. What is the relevance of antimicrobial resistance on the outcome of community-acquired pneumonia caused by Streptococcus pneumoniae? (should macrolide monotherapy be used for mild pneumonia?).
    Low DE.
    Infect Dis Clin North Am; 2013 Mar; 27(1):87-97. PubMed ID: 23398867
    [Abstract] [Full Text] [Related]

  • 25. Pneumococcal infection in children: rational antibiotic choice for drug-resistant Streptococcus pneumoniae.
    Chiou CC, Hseih KS.
    Acta Paediatr Taiwan; 2003 Mar; 44(2):67-74. PubMed ID: 12845845
    [Abstract] [Full Text] [Related]

  • 26. Therapy for pneumococcal infection at the millennium: doubts and certainties.
    Ball P.
    Am J Med; 1999 Jul 26; 107(1A):77S-85S. PubMed ID: 10451013
    [Abstract] [Full Text] [Related]

  • 27. Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
    Lismond A, Carbonnelle S, Verhaegen J, Schatt P, De Bel A, Jordens P, Jacobs F, Dediste A, Verschuren F, Huang TD, Tulkens PM, Glupczynski Y, Van Bambeke F.
    Int J Antimicrob Agents; 2012 Mar 26; 39(3):208-16. PubMed ID: 22245497
    [Abstract] [Full Text] [Related]

  • 28. A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae.
    Rzeszutek M, Wierzbowski A, Hoban DJ, Conly J, Bishai W, Zhanel GG.
    Int J Antimicrob Agents; 2004 Aug 26; 24(2):95-104. PubMed ID: 15288306
    [Abstract] [Full Text] [Related]

  • 29. Controversies in the treatment of pneumococcal community-acquired pneumonia.
    Feldman C, Anderson R.
    Future Microbiol; 2006 Oct 26; 1(3):271-81. PubMed ID: 17661640
    [Abstract] [Full Text] [Related]

  • 30. Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management.
    Fuller JD, McGeer A, Low DE.
    Eur J Clin Microbiol Infect Dis; 2005 Dec 26; 24(12):780-8. PubMed ID: 16344922
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Serotype distribution and antimicrobial resistance of adult Streptococcus pneumoniae clinical isolates over the period 2001-2008 in Crete, Greece.
    Maraki S, Mantadakis E, Samonis G.
    Chemotherapy; 2010 Dec 26; 56(4):325-32. PubMed ID: 20720416
    [Abstract] [Full Text] [Related]

  • 34. Drug-resistant Streptococcus pneumoniae--Kentucky and Tennessee, 1993.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1994 Jan 21; 43(2):23-6, 31. PubMed ID: 8277937
    [Abstract] [Full Text] [Related]

  • 35. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.
    Friedland IR, McCracken GH.
    N Engl J Med; 1994 Aug 11; 331(6):377-82. PubMed ID: 8028618
    [Abstract] [Full Text] [Related]

  • 36. The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae.
    Yayan J.
    Drug Des Devel Ther; 2014 Aug 11; 8():1733-43. PubMed ID: 25336917
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prevalence of penicillin-resistant Streptococcus pneumoniae--Connecticut, 1992-1993.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1994 Apr 01; 43(12):216-7, 223. PubMed ID: 8127327
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.